This is the authors' abstract. We don't add key points for this paper.
With the emergence of highly transmissible variants of concern, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) still poses a global threat of coronavirus disease 2019 (COVID-19) resurgence. Cellular responses to novel variants are more robustly maintained than humoral responses, and therefore, cellular responses are of interest in assessing immune protection against severe disease in the population. We aimed to assess cellular responses to SARS-CoV-2 at the population level. IFN
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hanssen et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: